DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Capecitabine
Capecitabine
A Phase II Study of Paclitaxel and Capecitabine As a First-Line Combination Chemotherapy for Advanced Gastric Cancer
A Phase II Study of Capecitabine and Docetaxel Combination Chemotherapy in Patients with Advanced Gastric Cancer
Metronomic Chemotherapy
Dosage of Capecitabine and Cyclophosphamide Combination Therapy in Patients with Metastatic Breast Cancer
Capecitabine Induces Rapid, Sustained Response in Two Patients with Extensive Oral Verrucous Carcinoma1
Colorectal Cancer
Predicted Concentrations of Anticancer Drugs in the Aquatic Environment
Dose-Finding Study of Capecitabine in Combination with Weekly Paclitaxel
Cancer Drug Costs for a Month of Treatment at Initial Food and Drug
Genetic Factors Influencing Pyrimidine- Antagonist Chemotherapy
Capecitabine
Chemotherapeutic Drugs in Lebanese Surface Waters: Estimation of Population Exposure and Identifcation of High-Risk Drugs
The Cost Burden of Blood Cancer Care a Longitudinal Analysis of Commercially Insured Patients Diagnosed with Blood Cancer
Phase II Study of Oral Capecitabine in Patients with Hormone-Refractory Prostate Cancer
Cancer Drug Costs for a Month of Treatment at Initial Food
Acronyms for Oncology Regimens
The Oral Fluoropyrimidines in Cancer Chemotherapy
2012 NIOSH List of Antineoplastic and Other Hazardous Drugs
Top View
XELODA (Capecitabine)
Esophageal and Esophagogastric Junction
Oral Chemotherapy Capecitabine (Xeloda®)
In Patients with Metastatic Breast Cancer
Modifying Chemotherapy for the Older Patient
Clinical Study Report
Xeloda, INN-Capecitabine
Chapter 12: Pharmacokinetics of Chemotherapeutic Agents in Kidney Disease
A Phase I and Pharmacokinetic Study of the Combination of Capecitabine
Preliminary Results of Tranilast Treatment for Patients with Advanced Castration-Resistant Prostate Cancer
LCA Oral SACT Counselling Handbook
Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
GICART Protocol.Pdf
HOPA News Volume 10, Issue 1
Capecitabine-Induced Hand-Foot Syndrome Complicated by Pseudomonal Superinfection Resulting in Bacterial Sepsis and Death Case Report and Review of the Literature
Capecitabine in Hormone-Resistant Metastatic Prostatic Carcinoma – a Phase II Trial
Emetogenic Potential of Antineoplastic Agents
Randomized Trial of Vitamin B6 for Preventing Hand-Foot Syndrome